SkinBioTherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is July - June.

Millions EUR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 29, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	61	51	21	25	37	116
Market Cap Growth	28.70%	141.64%	-16.68%	-31.73%	-68.18%	380.53%
Enterprise Value	57	50	18	24	33	110
Last Close Price	0.22	0.17	0.08	0.13	0.21	0.73
PS Ratio	11.33	9.37	14.72	163.89	424.66	-
PB Ratio	5.58	4.62	5.99	10.85	12.83	19.09
P/TBV Ratio	10.24	8.48	-	16.72	17.16	21.24
EV/Sales Ratio	10.63	9.33	12.45	158.92	384.18	-
Debt / Equity Ratio	0.11	0.11	0.28	0.05	0.05	0.03
Asset Turnover	0.54	0.54	0.31	0.05	0.02	-
Inventory Turnover	2.80	2.80	2.08	0.60	-	-
Quick Ratio	4.21	4.21	0.63	3.05	4.19	11.91
Current Ratio	4.84	4.84	0.93	3.25	4.58	12.50
Return on Equity (ROE)	-11.24%	-11.24%	-115.85%	-126.85%	-72.62%	-37.31%
Return on Assets (ROA)	-8.10%	-8.10%	-46.50%	-66.02%	-42.26%	-22.00%
Return on Capital Employed (ROCE)	-10.50%	-10.50%	-85.20%	-145.30%	-115.80%	-28.10%
Earnings Yield	-1.33%	-1.60%	-16.16%	-13.10%	-8.80%	-1.44%
FCF Yield	-2.36%	-2.85%	-15.40%	-12.64%	-8.42%	-1.56%
Buyback Yield / Dilution	-22.32%	-22.32%	-13.10%	-5.06%	-6.87%	-14.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.